| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e092ba7c0b4f2beba27b6420c0bd2ce |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-90 |
| filingDate |
2007-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbf2f2a9247324bbb5c3c15e88a40b9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f055a93edd0b92e23147019db00d6485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e67b1f8863fd933229aae9c0625ec889
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abdb54c692ecda4b6f44a7d871965f92 |
| publicationDate |
2010-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2009012155-A |
| titleOfInvention |
SYNERGIC PHARMACEUTICAL COMBINATION FOR CANCER TREATMENT. |
| abstract |
New pharmaceutical combination containing a cytotoxic antineoplastic agent selected from the group consisting of paclitaxel, docetaxel, doxorubicin or gemcitabine or a pharmaceutically acceptable salt thereof and at least one cyclin dependent kinase inhibitor (CDK); where the combination has a synergistic effect when used in the treatment of cancer. The invention also relates to a method for the treatment of cancer, in which a therapeutically effective amount of the combination is used. |
| priorityDate |
2007-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |